Prevention of cardiotoxicity in childhood cancer survivors: In physical exercise, we trust

Curr Probl Cardiol. 2024 Sep;49(9):102722. doi: 10.1016/j.cpcardiol.2024.102722. Epub 2024 Jun 20.

Abstract

In recent years, the mean survival rate of children after a cancer diagnosis has significantly improved. At the same time, a growing interest in short and long-term cardiovascular (CV) complications of cancer therapy, as well as long-term CV risk in childhood cancer survivors (CCS) developed, along with proposals of protocols for the diagnosis, management, and prevention of cancer therapy-related CV toxicity (CTR-CVT) in this population. Many clinical and individual risk factors for CTR-CVT have been identified, and a non-negligible prevalence of traditional CV risk factors has been described in this population, potentially associated with a further worsening in both CTR-CVT and long-term CV risk. Physical exercise (PE) represents a promising, free-of-cost and free-of-complications, helpful therapy for primary and secondary prevention of CTR-CVT in CCS. The present narrative review aims to summarize the most critical evidence available about CTR-CVT in CCS, focusing on the role of PE in this clinical scenario.

Keywords: Cancer therapy-related cardiovascular toxicity (CTR-CVT); Chemotherapy (CHT); Childhood cancer survivors (CCS); Physical exercise (PE); Radiotherapy (RT).

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cancer Survivors*
  • Cardiotoxicity* / etiology
  • Cardiotoxicity* / prevention & control
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Child
  • Exercise Therapy / methods
  • Exercise* / physiology
  • Humans
  • Neoplasms* / drug therapy
  • Risk Factors

Substances

  • Antineoplastic Agents